Last checked at 15 Jan 2015 12:14
For Immediate Release | 15 January 2015 |
Futura Medical plc
("Futura" or the "Company")
Director's Dealings
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has today received notification from James Barder, the Chief Executive of the Company, that he and his wife have gifted in aggregate 50,000 ordinary shares in the Company to a shareholding account jointly held by their children.
Following the transfer, Mr. Barder's revised aggregate beneficial and non-beneficial holding is 958,830 ordinary shares, representing 0.97 per cent. of the Company's issued share capital.
For further information please contact: For media enquiries please contact:
Futura Medical plc Buchanan Communications Limited | |
James Barder, Chief Executive Mark Court / Sophie Cowles + 44 (0) 1483 685 670 + 44 (0) 20 7466 5000 james.barder@futuramedical.com www.futuramedical.com |
|
Nominated AdviserN+1 SingerAubrey Powell+44 (0) 20 7496 3000 | |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com